Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
NLSPW
NLSPW News & Events
-
Add to Watchlist
Trade NLSPW
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
NLSPW News
NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs
Oct 30 2025
PRnewswire
NLS Pharmaceutics and Kadimastem Confirm Fulfillment of Key Conditions for Merger and Set Delisting Date for Kadimastem Shares
Oct 29 2025
Newsfilter
NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem
Oct 29 2025
PRnewswire
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
Oct 23 2025
PRnewswire
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
Sep 30 2025
PRnewswire
Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger
Sep 10 2025
PRnewswire
NLS Pharmaceutics Announces Positive Results from Study KO-943 Demonstrating Mazindol Reduces Fentanyl-Induced Reward in Animal Models
Apr 15 2025
PRnewswire
NLS Pharmaceutics Announces New Preclinical Data for AEX-2, Expanding the Therapeutic Potential of its Non-Sulfonamide Dual Orexin Receptor Agonist Platform
Feb 27 2025
PRnewswire
Show More News
NLSPW Events
No data
NLSPW Monitor News
No data
NLSPW Earnings Analysis
No Data
People Also Watch
